HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmelo Biondo Selected Research

Complementary Therapies (Alternative Medicine)

7/2023The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: "Attack on Titan".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmelo Biondo Research Topics

Disease

17Infections
02/2024 - 03/2005
5Melanoma (Melanoma, Malignant)
04/2016 - 12/2014
5Cryptococcosis
04/2013 - 05/2002
3Bacterial Infections (Bacterial Infection)
02/2024 - 01/2021
3Inflammation (Inflammations)
01/2021 - 09/2014
3Uveal melanoma
04/2016 - 02/2015
2Cross Infection (Nosocomial Infection)
08/2023 - 06/2023
2Hypersensitivity (Allergy)
11/2020 - 05/2002
2Neoplasms (Cancer)
04/2016 - 12/2014
2Sepsis (Septicemia)
01/2012 - 05/2004
2Bacteremia
04/2007 - 03/2007
1Critical Illness (Critically Ill)
07/2023
1COVID-19
06/2023
1Meningitis
10/2021
1Acanthamoeba Keratitis
10/2021
1Pneumococcal Infections
01/2020
1Pneumonia (Pneumonitis)
01/2020
1Encephalitis (Encephalitis, Rasmussen)
01/2020
1Peritonitis
01/2020
1Neoplasm Metastasis (Metastasis)
04/2016
1Meningioma (Meningiomas)
07/2015
1Candidiasis (Moniliasis)
10/2012
1Septic Shock (Toxic Shock Syndrome)
05/2004
1MYD88 Deficiency
05/2004

Drug/Important Bio-Agent (IBA)

8Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 01/2020
6Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2006
4VaccinesIBA
11/2020 - 01/2006
4CytokinesIBA
01/2020 - 07/2008
3ChemokinesIBA
01/2021 - 09/2014
2Interleukin-1 (Interleukin 1)IBA
01/2021 - 09/2014
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2021 - 09/2014
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2020 - 01/2020
2CadmiumIBA
02/2015 - 12/2014
2Polysaccharides (Glycans)IBA
04/2007 - 01/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005 - 05/2004
1HydrogelsIBA
08/2023
1ChitosanIBA
08/2023
1Anti-Infective Agents (Microbicides)IBA
06/2023
1Recombinant ProteinsIBA
11/2020
1Nucleic AcidsIBA
01/2020
1Bacterial DNAIBA
01/2020
1Myeloid Differentiation Factor 88IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1VitronectinIBA
10/2018
1Amphotericin B (Amphotericin)FDA LinkGeneric
12/2017
1CalciumIBA
04/2016
1Cell Adhesion MoleculesIBA
04/2016
1Cadherins (E-Cadherin)IBA
04/2016
1DecitabineFDA Link
04/2016
1EnzymesIBA
01/2016
1MicroRNAs (MicroRNA)IBA
07/2015
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
03/2015
1Histones (Histone)IBA
03/2015
1Caspase 8 (Caspase-8)IBA
02/2015
1Cyclin-Dependent Kinase Inhibitor p16IBA
02/2015
1IronIBA
04/2013
1Fibrinogen (Factor I)FDA Link
01/2013
1Fungal RNAIBA
10/2012
1polysialic acidIBA
04/2007
1Immune Sera (Antisera)IBA
04/2007
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
03/2007
1AntibodiesIBA
11/2005
1Interleukin-12 Subunit p40IBA
03/2005
1Interleukin-6 (Interleukin 6)IBA
05/2004
1Interleukin-2 (IL2)IBA
09/2003
1Interferon-gamma (Interferon, gamma)IBA
09/2003
1AntigensIBA
05/2002

Therapy/Procedure

2Therapeutics
10/2021 - 12/2017
1Catheters
02/2024
1Urinary Catheters
02/2024
1Complementary Therapies (Alternative Medicine)
07/2023